NCT03211169

Brief Summary

Prospective, randomized, multi-center study. Investigators will compare diagnostic yield of bile duct brushings, pediatric biopsy forceps biopsies and cholangioscopy-directed biopsies for obtaining diagnostic tissue from biliary strictures.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 7, 2017

Completed
22 days until next milestone

Study Start

First participant enrolled

July 29, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

November 8, 2019

Status Verified

November 1, 2019

Enrollment Period

2.1 years

First QC Date

June 30, 2017

Last Update Submit

November 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic tissue obtained as assessed by histologic evaluation of biopsy specimen

    Malignancy or no malignancy diagnosis obtained from stricture biopsy

    1 week

Secondary Outcomes (5)

  • Cost

    2 years

  • Radiation Exposure

    2 years

  • Procedure Duration

    2 years

  • Latency to diagnosis

    2 years

  • Adverse Events

    2 weeks

Study Arms (2)

Pediatric Biopsy Forceps directed biopsies

EXPERIMENTAL

Biopsies of the stricture will be taken with Pediatric Biopsy Forceps after bile duct brushings have been obtained.

Procedure: Biopsies of bile duct stricture with pediatric biopsy forceps

Cholangioscopy-directed biopsies

ACTIVE COMPARATOR

Biopsies of the stricture will be taken under cholangioscopic guidance after bile duct brushings have been obtained.

Procedure: Biopsies of bile duct stricture with cholangioscopy-directed biopsies

Interventions

Biopsies of the stricture will be taken to evaluate diagnostic yield of Pediatric Biopsy Forceps

Pediatric Biopsy Forceps directed biopsies

Biopsies of the stricture will be taken to evaluate diagnostic yield of cholangioscopy-directed biopsies

Cholangioscopy-directed biopsies

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with obstructive jaundice, and imaging (CT or MRI) suggestive of biliary stricture, without obvious pancreatic mass
  • All patients with obstructive jaundice, and index ERCP suggestive of biliary stricture, without obvious pancreatic mass
  • All patients with obstructive jaundice, and prior ERCP suggestive of biliary stricture
  • Expected patient survival of at least 90 days
  • High likelihood of patient follow-up
  • Patient is able to give a written informed consent
  • Patient is willing and able to comply with the study procedures

You may not qualify if:

  • Patients with imaging suggestive of pancreatic tumor
  • Children \< 18 years of age
  • Pregnant women
  • Patients with impaired decision-making
  • Healthy volunteers
  • Primary Sclerosing Cholangitis (PSC)
  • Patients with untreated coagulopathy at the time of procedure or ongoing need for anti-coagulation
  • Patients with any contraindication to endoscopic procedure
  • Participation in another investigational study that may directly or indirectly affect the results of this study within 30 days prior to the initial visit
  • Patients unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University Medical Center

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

CholangiocarcinomaConstriction, Pathologic

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Randomized prospective study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine, Division of Gastroenterology

Study Record Dates

First Submitted

June 30, 2017

First Posted

July 7, 2017

Study Start

July 29, 2017

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

November 8, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations